Health services research and geriatrics: Deficits and research approaches using the example of colorectal carcinoma and anaemia;Versorgungsforschung und Geriatrie: Defizite und Forschungsansätze am Beispiel des Kolorektalen Karzinoms und der Anämie

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 101, Issue 9, 2007, Pages 587-592

  Wedding, Ulrich ^a,b   Höffken, Klaus ^a   Friedrich, Christoph ^b   Pientka, Ludger ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Anaemia; Cancer; Colorectal carcinoma; Early detection; Health services research

Indexed keywords

EID: 38849174472     PISSN: 14317621     EISSN: 16180992     Source Type: Journal    
DOI: 10.1016/j.zgesun.2007.09.005     Document Type: Article

References (31)

1. Jemal, A., et al., Cancer statistics, 2006. CA Cancer J Clin, 2006. 56(2): p. 106-30.
2. Edwards, B.K., et al., Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer, 2002. 94(10): p. 2766-92.
3. Anisimov, V.N., The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol, 2003. 45(3): p. 277-304.
4. Hutchins, L.F., et al., Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med, 1999, 341(27): p. 2061-7.
5. Lewis, J. H., et al., Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol, 2003. 21(7): p. 1383-9.
6. Talarico, L., G. Chen, and R. Pazdur, Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol, 2004. 22(22): p. 4626-31.
7. Harter, P., et al., Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Ann Oncol, 2005, 16(11): p. 1801-5.
8. Townsley, C.A., et al., Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns. J Clin Oncol, 2003. 21(24): p, 4627-35.
9. Kemeny, M.M., et al., Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol, 2003. 21(12): p, 2268-75.
10. Avis, N.E,, et al., Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol, 2006, 24(12): p. 1860-7.
11. Townsley, C.A., et al., Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer, 2006. 6(1): p. 34.
12. Fearon, E.R. and B. Vogelstein, A genetic model for colorectal tumorigenesis. Cell, 1990. 61(5): p. 759-67.
13. Mandel, J.S., et al., Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med, 1993. 328(19): p. 1365-71.
14. Citarda, F., et al., Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut, 2001. 48(6): p. 812-5.
15. Winawer, S.J., et al,, Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med, 1996, 334(2): p. 82-7.
16. Twelves, C., et al., Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med, 2005. 352(26): p. 2696-704.
17. Andre, T., et al., Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage Il and III colon cancer: results of a randomized trial. J Clin Oncol, 2003. 21(15): p. 2896-903.
18. Andre, T., et al., Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 2004. 350(23): p. 2343-51.
19. Jessup, J.M,, et al., Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. Jama, 2005, 294(21): p. 2703-11.
20. Sundararajan, V., et al., Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med, 2002. 136(5): p. 349-57.
21. Sargent, D.J., et al., A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med, 2001. 345(15): p. 1091-7.
22. Popescu, R.A., et al., Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol, 1999. 17(8): p. 2412-8.
23. Neugut, A.I., et al., Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly. J Clin Oncol, 2006. 24(15): p. 2368-2375.
24. Grothey, A., L. Kellermann, and H.J. Schmoll, [Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms]. Med Klin (Munich), 2002. 97(5): p. 270-7.
25. Fietkau, R., et al., Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry Strahlenther Onkol, 2004. 180(8): p. 478-87.
26. Guralnik, J.M., et al., Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood, 2004. 104(8): p. 2263-8.
27. Steinhagen-Thiessen, E. and M. Borchelt, Morbidität, Medikation und Funktionalität im Alter, in Die Berliner Altersstudie, P.B. Baltes, Editor. 1996, Akademie Verlag: Berlin.
28. Beghe, C,. A. Wilson, and W.B. Ershler, Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med, 2004. 116 Suppl 7A: p. 3S-10S.
29. Chaves, P.H., et al., What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc, 2004. 52(11): p. 1811-6.
30. Denny, S.D., M.N. Kuchibhatla, and H.J. Cohen, Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med, 2006. 119(4): p. 327-34.
31. Penninx, B.W., et al., Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci, 2006. 61 (5): p. 474-9.